Title: Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis
and cirrhosis in COVID-19 patients with concurrent liver diseases
Version: 0 Date: 09 Feb 2025
Reviewer's report:
Title: Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis
and cirrhosis in COVID-19 patients with concurrent liver diseases
Version: 0 Date: 09 Feb 2025
Reviewer's report:
Please review this paper.
user
Title: Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis
and cirrhosis in COVID-19 patients with concurrent liver diseases
Version: 0 Date: 09 Feb 2025
Reviewer's report:
assistant